Global Blood Therapeutics, Inc. Receivables, Net, Current
Global Blood Therapeutics, Inc. had Receivables, Net, Current of $29.77 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2022-08-08
- 2022-06-30: Receivables, Net, Current $29.77M.
- 2022-03-31: Receivables, Net, Current $27.73M.
- 2021-12-31: Receivables, Net, Current $28.80M.
- 2021-09-30: Receivables, Net, Current $23.89M.
| Period end | Receivables, Net, Current |
|---|---|
| 2022-06-30 | $29.77M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $27.73M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $28.80M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $23.89M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $19.54M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $18.27M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $17.50M 10-K · filed 2022-02-23 |
| 2020-09-30 | $14.13M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $12.47M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $4.58M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $2.64M 10-K · filed 2021-02-24 |